These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4568350)

  • 1. Studies on 2-(3-benzoylphenyl) propionic acid (Orudis). A double-blind cross-over trial in patients with rheumatoid arthritis and an assessment of its influence on hepatic drug-metabolizing enzymes.
    Cathcart BJ; Vince JD; Gordon AJ; Bell MA; Chalmers IM
    Ann Rheum Dis; 1973 Jan; 32(1):62-5. PubMed ID: 4568350
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind cross-over study of Orudis and placebo in fifty patients with rheumatoid arthritis.
    Zutshi DW; Marr S; Bloch M; Mason RM
    Rheumatol Rehabil; 1973 May; 12(2):62-7. PubMed ID: 4582347
    [No Abstract]   [Full Text] [Related]  

  • 3. Ketoprofen: double-blind cross-over study with indomethacin in patients with rheumatoid arthritis.
    Zutshi DW; Stern D; Bloch M; Mason RM
    Rheumatol Rehabil; 1974 Feb; 13(1):10-6. PubMed ID: 4604659
    [No Abstract]   [Full Text] [Related]  

  • 4. [Double-blind tests on the therapeutic activity of ketoprophene against rheumatoid arthritis].
    Giordano M; Tirri G; Gallo M; Ara M
    Farmaco Prat; 1974 Nov; 29(11):621-8. PubMed ID: 4611795
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of 19583RP (ketoprofen) in the treatment of chronic rheumatoid arthritis].
    Shiokawa Y; Abe T; Onoda T
    Ryumachi; 1974 Oct; 14(3):279-86. PubMed ID: 4615379
    [No Abstract]   [Full Text] [Related]  

  • 6. Orudis in management of rheumatoid arthritis and osteoarthrosis of the hip: comparison with indomethacin.
    Gyory AN; Bloch M; Burry HC; Grahame R
    Br Med J; 1972 Nov; 4(5837):398-400. PubMed ID: 4564764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of ketoprofen in rheumatoid arthritis--early phase II study by multi-clinical trial. New drug research group.
    Ryumachi; 1973 Jul; 13(3):256-60. PubMed ID: 4755623
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind comparison of ibuprofen and phenylbutazone in a short-term treatment of rheumatoid arthritis.
    Pavelka K; Susta A; Vojtísek O; Brémová A; Kanková D; Hándlová D; Malecek J
    Arzneimittelforschung; 1973 Jun; 23(6):842-6. PubMed ID: 4579953
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis: a double-blind cross-over comparison with indomethacin.
    Kirchheiner B; Fossgreen J; Tophoj E; Zachariae E
    Rheumatol Rehabil; 1976; Suppl():50-1. PubMed ID: 796942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the therapeutic potential of ketoprofen in rheumatoid arthritis.
    Anderson JA; Lee P; Webb J; Bachanan WW
    Curr Med Res Opin; 1974; 2(4):189-97. PubMed ID: 4601567
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of a controlled clinical double blind study between isobutylphenylpropionic acid and indomethacin].
    Colombo B; Chérié Ligniére G; Carrabba M
    Minerva Med; 1973; 64(48):2522-6. PubMed ID: 4580155
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of keto profen (Orudis) in rheumatoid arthritis: results of a multi-centre double-blind trial against phenylbutazone.
    Sydnes OA; Brath HK; Haerum LB; Straume S
    Rheumatol Rehabil; 1976; Suppl():43-4. PubMed ID: 796940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of naproxen and indomethacin in rheumatoid arthritis.
    Szanto E
    Scand J Rheumatol; 1974; 3(3):118-20. PubMed ID: 4610736
    [No Abstract]   [Full Text] [Related]  

  • 14. Ketoprofen: a preliminary report of its pharmacological activity and therapeutic efficacy in rheumatic disorders.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1974; 8(3):168-75. PubMed ID: 4611741
    [No Abstract]   [Full Text] [Related]  

  • 15. Naproxen: a novel approach to dose-finding efficacy trails in rheumatoid arthritis.
    Lussier A; Segre EJ; Multz CV; MacCannell K; Alexander SJ; Howard DL; Boost G; Varady J; Strauss W
    Clin Pharmacol Ther; 1973; 14(3):434-41. PubMed ID: 4572801
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind crossover comparison of Orudis (ketoprofen) and indomethacin in the treatment of rheumatoid arthritis.
    Digby JW; Wehner S
    J Int Med Res; 1976; 4(6):427-31. PubMed ID: 800382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-blind crossover comparison of fenoprofen, ibuprofen and naproxen in rheumatoid arthritis.
    Reynolds PM; Whorwell PJ
    Curr Med Res Opin; 1974; 2(8):461-4. PubMed ID: 4614951
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trial of a new phenylalcanoic acid derivative].
    Chériè Lignière G; Colombo B; Carrabba M
    Minerva Med; 1973 May; 64(34):1815-20. PubMed ID: 4578239
    [No Abstract]   [Full Text] [Related]  

  • 19. A controlled trial of tiaprofenic acid versus ibuprofen in rheumatoid arthritis.
    Daymond TJ; Thompson M; Akbar FA; Chestney V
    Rheumatol Rehabil; 1979 Nov; 18(4):257-60. PubMed ID: 390674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A double-blind multi-center clinical trial of benoxaprofen against indomethacin in rheumatoid arthritis (author's transl)].
    Shichikawa K; Aritomi H; Ogawa N
    Ryumachi; 1982 Feb; 22(1):88-102. PubMed ID: 7046091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.